Back to search

Duquesne

Computational Modeling of the Binding of Amyloid-Beta to Neprilysin for Facilitating the Development of a Potential Alzheimer's Disease Therapy

Abstract

dc:description.abstract

The zinc metalloprotease neprilysin (NEP) has been shown to degrade small bioactive peptides. Crystal structures of seven NEP-inhibitor complexes and biochemical characterization of NEP activity have highlighted amino acid interactions that are crucial to ligand binding. Studies also indicate that NEP is one of a select group of metalloenzymes that degrade the amyloid-beta peptide (Aß) in vivo and in situ. Accumulation of neurotoxic Aß aggregates in the brain appears to be a causative agent in the pathophysiology of Alzheimer's Disease (AD). For this reason the enzymatic degradation of Aß has been studied extensively, but little is known about specific binding interactions underlying NEP degradation of Aß. Using known crystal structures of NEP, we have conducted comparative computational studies of ligand binding that predict NEP residues Arg 102 and 110 form binding interactions specific to Aß. These interactions may provide insight for using NEP degradation of Aß in AD therapy.

Degree

thesis:*
Name thesis:degree_name
MS
Level thesis:degree_level
Immediate Access
Discipline thesis:degree_discipline
Chemistry and Biochemistry

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Pope, Darrick E.
Contributors dc:contributor
  • Michael Cascio
  • Jeffry Madura
  • Rita Mihailescu

Subjects

dc:subject × 6

Rights

Language dc:language
English

Identifiers

dc:identifier.*
Repository record dc:identifier
https://dsc.duq.edu/etd/1507

Chain of custody

source
Harvested from
Duquesne
Base URL
dsc.duq.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Pope, Darrick E.. Computational Modeling of the Binding of Amyloid-Beta to Neprilysin for Facilitating the Development of a Potential Alzheimer's Disease Therapy. Immediate Access thesis, https://dsc.duq.edu/etd/1507